靶向神经系统癌症中的长非编码 RNA:预后、诊断和治疗的新见解。

Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis and Therapy.

机构信息

Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, 4 Soranou Efesiou Str, 115 27, Athens, Greece.

出版信息

Curr Med Chem. 2019;26(30):5649-5663. doi: 10.2174/0929867325666180831170227.

Abstract

Long non-coding RNAs (lncRNAs) constitute one of the most broad and diverse classes of cellular transcripts, playing key roles as regulatory molecules in many biological processes. Although the biology of lncRNAs is a new and emerging field of research, several studies have already shown that alterations in the expression of lncRNAs are associated with the development and progression of cancer in different organs and tissues, including central and peripheral nervous system. In this review, we summarize the oncogenic and tumor suppressive roles of lncRNAs in malignant tumors of the nervous system, such as glioma and neuroblastoma, focusing on their functional interactions with DNA, other RNA and protein molecules. We further discuss the potential use of lncRNAs as biomarkers for diagnosis, prognosis and tumor treatment. Gaining insight into the functional association between nervous system malignancies and lncRNAs could offer new perspectives to the development of promising therapeutic tools against cancer.

摘要

长非编码 RNA(lncRNAs)是细胞转录本中最广泛和多样化的一类,作为许多生物过程中的调节分子发挥着关键作用。尽管 lncRNA 的生物学是一个新出现的研究领域,但已有多项研究表明,lncRNA 的表达改变与不同器官和组织包括中枢和外周神经系统的癌症的发生和发展有关。在这篇综述中,我们总结了 lncRNA 在神经系 统恶性肿瘤(如胶质瘤和神经母细胞瘤)中的致癌和肿瘤抑制作用,重点讨论了它们与 DNA、其他 RNA 和蛋白质分子的功能相互作用。我们还进一步讨论了将 lncRNA 用作诊断、预后和肿瘤治疗的生物标志物的潜在用途。深入了解神经系统恶性肿瘤与 lncRNA 之间的功能关联,可为开发针对癌症的有前途的治疗工具提供新的视角。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索